Earnings Call · Q3 FY2024·2024-11-12

Q3 24EPS -56.67%·Rev n/aQ2 24EPS -13.64%·Rev n/aQ1 24EPS -20.00%·Rev n/aQ4 23EPS +34.78%·Rev n/a⚠ consensus missing

Wave Life Sciences, Inc. WVE

Kate Rausch — Vice President, Investor Relations

Paul Bolno — President and Chief Executive Officer

Anne-Marie Li-Kwai-Cheung — Chief Development Officer

Kyle Moran — Unclear, likely a company employee involved in the call

−3.3%1d on move date−3.0% vs SPY3d−8.8%5d−21.8%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more WVE calls or request research access.

More WVE calls Browse calls Request research access